Ekso Bionics Holdings, Inc. EKSO
Jul 2, 2026, 3:24 PM EDT
52-week range unavailable
- YTD
- +84.03%
- 1 year
- +165.00%
- Market cap
- 13.31M
- Revenue (ttm)
- 17.68M
- Profit margin
- -62.95%
- Shares out
- 22.00M
- Forward P/E
- -3.18
- YTD return
- +84.03%
- 1-year return
- +165.00%
- Volume
- 133.57K
- Open
- 17.85
- Previous close
- 15.90
- Day's range
- 15.75 – 18.12
- Beta
- 1.48
- Price target
- 5.50 (-65.4%)
1Y +4.50 (+62.94%)
Key statistics
- Enterprise value
- 10.82M
- PEG ratio
- 0.00
- Price / sales
- 0.75
- Price / book
- 0.89
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -10.40%
- Free cash flow
- -4.85M
- Total cash
- 8.29M
- Total debt
- 6.35M
- Return on equity
- -73.89%
- Short % of float
- 0.57%
- 50-day average
- 0.81116
- 200-day average
- 1.10
Analyst view
- Target (low)
- 2.00
- Target (mean)
- 5.50
- Target (high)
- 9.00
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 28, 2024 | Sep 1, 2024 | -0.08 | -0.10 | -0.02 | -25.00% |
| Jul 29, 2024 | Jun 1, 2024 | -0.11 | -0.13 | -0.02 | -18.18% |
| Apr 29, 2024 | Mar 1, 2024 | -0.16 | -0.20 | -0.04 | -25.00% |
| Mar 4, 2024 | Dec 1, 2023 | -0.11 | -0.22 | -0.11 | -100.00% |
| Oct 26, 2023 | Sep 1, 2023 | -0.31 | -0.24 | +0.07 | +22.58% |
| Jul 27, 2023 | Jun 1, 2023 | -0.28 | -0.31 | -0.03 | -10.71% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2024 | Lake Street | main | Buy | Buy |
| Oct 29, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Jul 30, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 24, 2024 | Lake Street | init | — | Buy |
| Apr 30, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Mar 5, 2024 | HC Wainwright & Co. | main | Buy | Buy |
About Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- eksobionics.com
News
ChronoScale Reports Fiscal First Quarter 2027 Results 
ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Passes Above 50-Day Moving Average – What’s Next? 
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth 
Insider Buying: Ekso Bionics (NASDAQ:EKSO) Major Shareholder Purchases $191,142.00 in Stock 
Ekso Bionics Prices $5.852 million Private Placement 
Why Applied Digital Stock Is Jumping Today 
Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights 
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO) 
Consumer Tech News (Dec 31-Jan 2): Wall Street Braces for Sluggish 2026 Start, AI Spending, and Chip Wars Define Market Pulse & More 
Consumer Tech News (Dec 31-Jan 2): Wall Street Braces for Sluggish 2026 Start, AI Spending, and Chip Wars Define Market Pulse & More
Your note
Sign in to keep a note on EKSO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CLOYD MARY ANN | Director | Stock Award(Grant) | Jun 5, 2024 | 220,505 |
| DAVIS SCOTT GERALD | President | Sale | Aug 16, 2023 | 331,372 |
| JONES JASON C | Chief Operating Officer | Stock Award(Grant) | Mar 21, 2024 | 0 |
| LATHAN CORINNA | Director | Stock Award(Grant) | Jun 5, 2024 | 226,207 |
| LI KECHENG | Director | Stock Award(Grant) | Jun 5, 2024 | 224,738 |
| SCHER DEBORAH LAFER | Director | Stock Award(Grant) | Jun 5, 2024 | 78,217 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.85% | 2,167,000 | 1.31M | Sep 29, 2024 |
| Kent Lake PR LLC | 7.59% | 1,669,700 | 1.01M | Sep 29, 2024 |
| Vanguard Group Inc | 2.70% | 594,427 | 359.63K | Sep 29, 2024 |
| Cresset Asset Management, LLC | 2.34% | 515,615 | 311.95K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.76% | 167,308 | 101.22K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.34% | 74,616 | 45.14K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.82% | 400,887 | 242.54K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.82% | 179,455 | 108.57K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.48% | 105,163 | 63.62K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 24,854 | 15.04K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 14,838 | 8.98K | Oct 30, 2024 |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 0.06% | 14,085 | 8.52K | Sep 29, 2024 |